Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. GRASSLEY CONFIRMS DELAY ON DRUG BILL WHILE ANOTHER COMMITTEE PLANS VOTES Senate Finance Committee Chairman Chuck Grassley, R-Iowa, last week confirmed that his planned drug pricing legislation won’t be unveiled until after lawmakers return from a the … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Pharma industry CEOs testify before a Senate committee; House and Senate panels probe insulin prices; medical device tax suspension bills to be introduced; Gottlieb to testify before House panel; and more.… Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address; Democrats criticize HHS’ drug rebate proposal; dueling hearings highlight the ACA’s pre-existing conditions; House Democrat reveals her cancer is … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: With the shutdown over (for now), the FDA is back in business; two hearings spotlight drug prices; House GOP questions CMS on Medicaid managed care; and more.… Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. We’re posting on Tuesday this week because of the Martin Luther King, Jr. federal holiday. Highlights this week: Gottlieb warns FDA’s funds running low as shutdown continues; House Dems launch sweeping probe on drug prices, Senate approves … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Nearly 7,000 FDA employees are furloughed amid the ongoing government shutdown; lawmakers introduce a slew of anti-pharma bills; 18 new Democrats land plum spots on key healthcare committees; and more.… Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: how the partial government shutdown is affecting operations at the FDA; House Democrats take steps to defend the ACA; the House votes this week to renew emergency health response programs; new senators are added … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Lawmakers renew efforts to avoid a partial government shutdown, which would affect FDA; key senators introduce legislation on Medicaid prescription drug rebates; the House votes this week on allowing states to coordinate care for … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Healthcare legislative priorities are caught up in a separate spending debate that could lead to a partial government shutdown; some GOP lawmakers push back on Trump’s Part B pilot program; a key Democrat says … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Democrats’ takeover of the House will yield big changes for healthcare policy in 2019; several GOP lawmakers active in healthcare policy are defeated; pharma pushes for Part D changes in the lame duck; and … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Included this week is an update on congressional efforts to finish opioids response legislation; efforts by pharmaceutical manufacturers to change discounts they are required to provide Medicare beneficiaries in the Part D donut hole; the status of … Continue Reading
The Senate this week overwhelmingly approved legislation to address the opioid crisis, and now Congress is racing to cobble together a final measure that could pass before the midterm elections in November. The Senate-passed legislation is sweeping in scope: It is composed of more than 70 individual bills approved by five committees. Packaged together, this legislation … Continue Reading
Below is this week’s “Capitol Hill Healthcare Update,” posted on Mondays when Congress is in session. Featured in this week’s Update, the Senate votes today on opioids legislation (the House is not in session this week); Congress reaches an agreement on fiscal 2019 healthcare funding; the pharma industry last week suffers both a setback and … Continue Reading